Key Metrics of Repligen
Revenue$632M▼ 21.1% YoYFY 2023
Operating income$47.7M▼ 78.8% YoY
Net profit$35.6M▼ 80.9% YoY
Shareholders' equity$2.0B
Market cap$8.7BRGEN · $178.71
Competitors10identified
Open jobs2
About Repligen
Sectors
Company details
- Website
- repligen.com
- Founded
- 1986
- Listed
- Nasdaq: RGEN (since 1986)
Operational Areas of Repligen
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameRepligen Corporation
TickerRGEN
ExchangeNasdaq
CountryUnited States
SEC CIK0000730272
Listed since1986
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.repligen.com
US market & SEC filings
RGEN · Nasdaq · SEC CIK 0000730272
Last price · 24 Oct 2026
$178.71
−0.72%
Market cap$8.7B
P/E283.7On FY 2023 diluted EPS
Volume1,272,539
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 1986
RGEN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeWaltham
GSTIN—
Email—
Websitehttp://www.repligen.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Repligen
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.